CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
InMuMyel I Study	2011-05-19	Registered
GrUVen-I Study	2011-05-03	Registered
EGFpeeling I	2011-05-03	Registered
Clinical Trial Heberbiovac HB vaccine Material Reference Batch	2011-05-16	Registered
NASVAC therapeutic vaccine study	2011-05-16	Registered
Heberprovac Study	2011-05-16	Registered
TS-FARMEV Study	2011-05-16	Registered
CERVISEG-300-I Study	2011-05-17	Registered
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study.	2011-04-28	Registered
CENTAURO Study	2011-04-29	Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.	2011-04-29	Registered
NEUVITAL V Study	2011-04-30	Registered
Change in Manufacture Process of Heberbiovac HB vaccine.	2011-04-30	Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks.	2011-04-27	Registered
CIGB500 in healthy volunteers	2010-12-20	Registered
THERESA-2 Study	2010-12-20	Registered
THERESA	2008-10-07	Registered
Safety and immunogenicity of commercial Hepatitis B vaccines.	2009-02-27	Registered
Dynamic-I	2010-12-20	Registered
FarmaPEG-I	2008-10-07	Registered